AMLX fundamentals
Amylyx Pharmaceuticals, Inc. earnings per share and revenue
AMLX earnings per share for the last quarter are -0.55 USD whereas the estimation was -0.52 USD which accounts for -5.77% surprise. Company revenue for the same period amounts to -665.00 k USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.50 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of AMLX earnings per share and revenue dynamics.
Next report date
≈
Report periodQ1 2025
EPS estimate−0.50USD
Revenue estimate—
EPS
Forecast
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−1.80
−1.20
−0.60
0.00
0.60
Reported
Estimate
Currency: USD
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.02
0.31
0.30
0.07
−1.75
−1.07
−1.07
−0.55
—
—
—
—
Estimate
−0.24
0.19
0.44
0.23
0.00
−0.73
−0.70
−0.52
−0.50
−0.50
−0.50
−0.49
Surprise
+108.31%
+63.16%
−31.43%
−69.27%
−43,650.00%
−46.58%
−51.99%
−5.77%
—
—
—
—
Revenue
Forecast
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−40.00 M
0.00
40.00 M
80.00 M
120.00 M
Reported
Estimate
Currency: USD
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
71.43 M
98.20 M
102.69 M
108.45 M
88.60 M
−1.02 M
416.00 K
−665.00 K
—
—
—
—
Estimate
58.99 M
92.21 M
113.66 M
106.96 M
98.35 M
10.66 M
0.00
0.00
0.00
0.00
0.00
0.00
Surprise
+21.09%
+6.49%
−9.65%
+1.39%
−9.91%
−109.59%
—
—
—
—
—
—